HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 69 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,584,761 | +41.2% | 1,802,963 | -0.1% | 0.49% | +59.5% |
| Q2 2023 | $21,666,996 | -8.9% | 1,805,583 | -1.2% | 0.31% | -10.4% |
| Q1 2023 | $23,787,149 | -16.3% | 1,826,970 | +2.6% | 0.34% | -8.5% |
| Q4 2022 | $28,427,761 | +78.3% | 1,780,144 | +1.3% | 0.38% | +64.6% |
| Q3 2022 | $15,947,000 | -25.3% | 1,758,075 | +0.1% | 0.23% | -24.2% |
| Q2 2022 | $21,359,000 | -35.5% | 1,756,307 | +0.3% | 0.30% | -21.6% |
| Q1 2022 | $33,123,000 | -12.3% | 1,750,690 | +62.6% | 0.38% | -1.0% |
| Q4 2021 | $37,777,000 | +2.6% | 1,076,870 | +7.0% | 0.39% | +4.0% |
| Q3 2021 | $36,835,000 | +8.5% | 1,006,147 | +16.3% | 0.37% | +13.0% |
| Q2 2021 | $33,959,000 | +23.2% | 864,760 | -11.4% | 0.33% | +13.4% |
| Q1 2021 | $27,558,000 | -9.2% | 975,488 | +2.9% | 0.29% | -16.1% |
| Q4 2020 | $30,345,000 | -0.9% | 947,674 | 0.0% | 0.35% | -17.7% |
| Q3 2020 | $30,610,000 | +17.1% | 947,674 | 0.0% | 0.42% | +14.3% |
| Q2 2020 | $26,137,000 | +71.9% | 947,674 | +11.2% | 0.37% | +25.4% |
| Q1 2020 | $15,208,000 | -25.8% | 851,994 | +4.2% | 0.30% | -9.2% |
| Q4 2019 | $20,503,000 | +48.7% | 817,817 | +3.8% | 0.32% | +27.0% |
| Q3 2019 | $13,788,000 | +4.7% | 788,198 | +31.7% | 0.26% | +13.8% |
| Q2 2019 | $13,163,000 | -28.1% | 598,310 | 0.0% | 0.22% | -77.7% |
| Q1 2019 | $18,296,000 | +80.0% | 598,310 | +35.9% | 1.01% | +50.7% |
| Q4 2018 | $10,164,000 | -21.1% | 440,169 | +10.0% | 0.67% | -18.2% |
| Q3 2018 | $12,877,000 | +28.5% | 400,029 | +20.3% | 0.82% | -4.3% |
| Q2 2018 | $10,023,000 | +12.1% | 332,536 | +10.0% | 0.85% | -3.6% |
| Q1 2018 | $8,940,000 | +70.0% | 302,420 | +125.9% | 0.89% | +61.4% |
| Q4 2017 | $5,258,000 | +200.3% | 133,850 | +107.3% | 0.55% | +200.0% |
| Q3 2017 | $1,751,000 | +156.7% | 64,573 | +120.8% | 0.18% | +125.9% |
| Q2 2017 | $682,000 | – | 29,242 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
| UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
| Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
| Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
| Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
| AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
| York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
| M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |